• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体因子 B 在高糖诱导的足细胞损伤和糖尿病肾病中的作用。

Complement factor B in high glucose-induced podocyte injury and diabetic kidney disease.

机构信息

Center for Kidney Disease and.

Department of Clinical Genetics, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.

出版信息

JCI Insight. 2021 Oct 8;6(19):e147716. doi: 10.1172/jci.insight.147716.

DOI:10.1172/jci.insight.147716
PMID:34622800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8525650/
Abstract

The role and mechanisms for upregulating complement factor B (CFB) expression in podocyte dysfunction in diabetic kidney disease (DKD) are not fully understood. Here, analyzing Gene Expression Omnibus GSE30528 data, we identified genes enriched in mTORC1 signaling, CFB, and complement alternative pathways in podocytes from patients with DKD. In mouse models, podocyte mTOR complex 1 (mTORC1) signaling activation was induced, while blockade of mTORC1 signaling reduced CFB upregulation, alternative complement pathway activation, and podocyte injury in the glomeruli. Knocking down CFB remarkably alleviated alternative complement pathway activation and DKD in diabetic mice. In cultured podocytes, high glucose treatment activated mTORC1 signaling, stimulated STAT1 phosphorylation, and upregulated CFB expression, while blockade of mTORC1 or STAT1 signaling abolished high glucose-upregulated CFB expression. Additionally, high glucose levels downregulated protein phosphatase 2Acα (PP2Acα) expression, while PP2Acα deficiency enhanced high glucose-induced mTORC1/STAT1 activation, CFB induction, and podocyte injury. Taken together, these findings uncover a mechanism by which CFB mediates podocyte injury in DKD.

摘要

在糖尿病肾病(DKD)中,足细胞功能障碍中补体因子 B(CFB)表达上调的作用和机制尚不完全清楚。在这里,通过分析基因表达综合数据库 GSE30528 数据,我们鉴定了 DKD 患者足细胞中富含 mTORC1 信号、CFB 和补体替代途径的基因。在小鼠模型中,诱导足细胞 mTOR 复合物 1(mTORC1)信号激活,而阻断 mTORC1 信号可减少 CFB 的上调、替代补体途径的激活以及肾小球中的足细胞损伤。敲低 CFB 可显著减轻糖尿病小鼠中替代补体途径的激活和 DKD。在培养的足细胞中,高葡萄糖处理激活 mTORC1 信号,刺激 STAT1 磷酸化,并上调 CFB 表达,而阻断 mTORC1 或 STAT1 信号可消除高葡萄糖上调的 CFB 表达。此外,高葡萄糖水平下调蛋白磷酸酶 2Acα(PP2Acα)的表达,而 PP2Acα 缺乏增强高葡萄糖诱导的 mTORC1/STAT1 激活、CFB 诱导和足细胞损伤。总之,这些发现揭示了 CFB 介导 DKD 中足细胞损伤的一种机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/913dedc36eff/jciinsight-6-147716-g048.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/f103d64e50b2/jciinsight-6-147716-g042.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/12884ee54f1c/jciinsight-6-147716-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/80432b0342fd/jciinsight-6-147716-g044.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/6e36458745ca/jciinsight-6-147716-g045.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/9b518a285877/jciinsight-6-147716-g046.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/4623beb1b70c/jciinsight-6-147716-g047.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/913dedc36eff/jciinsight-6-147716-g048.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/f103d64e50b2/jciinsight-6-147716-g042.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/12884ee54f1c/jciinsight-6-147716-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/80432b0342fd/jciinsight-6-147716-g044.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/6e36458745ca/jciinsight-6-147716-g045.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/9b518a285877/jciinsight-6-147716-g046.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/4623beb1b70c/jciinsight-6-147716-g047.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40cd/8525650/913dedc36eff/jciinsight-6-147716-g048.jpg

相似文献

1
Complement factor B in high glucose-induced podocyte injury and diabetic kidney disease.补体因子 B 在高糖诱导的足细胞损伤和糖尿病肾病中的作用。
JCI Insight. 2021 Oct 8;6(19):e147716. doi: 10.1172/jci.insight.147716.
2
Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.足细胞中蛋白酪氨酸磷酸酶1B缺乏可减轻高血糖诱导的肾损伤。
Metabolism. 2017 Nov;76:56-69. doi: 10.1016/j.metabol.2017.07.009. Epub 2017 Aug 8.
3
Dihydroxyacetone phosphate accumulation leads to podocyte pyroptosis in diabetic kidney disease.二羟丙酮磷酸积累导致糖尿病肾病足细胞细胞焦亡。
J Cell Mol Med. 2024 Feb;28(3):e18073. doi: 10.1111/jcmm.18073. Epub 2023 Dec 8.
4
The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1.多囊蛋白-1的C末端尾巴通过信号转导和转录激活因子1调节补体因子B的表达。
Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1284-94. doi: 10.1152/ajprenal.00428.2015. Epub 2016 Mar 16.
5
PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.PKFP 激活可改善糖尿病肾病足细胞足突融合。
Front Endocrinol (Lausanne). 2022 Jan 14;12:797025. doi: 10.3389/fendo.2021.797025. eCollection 2021.
6
MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.在糖尿病肾病小鼠中,MYDGF通过激活Akt/BAD信号通路减轻足细胞损伤和蛋白尿。
Diabetologia. 2020 Sep;63(9):1916-1931. doi: 10.1007/s00125-020-05197-2. Epub 2020 Jun 25.
7
Deciphering the molecular nexus of BTG2 in periodontitis and diabetic kidney disease.解析 BTG2 在牙周炎和糖尿病肾病中的分子关联。
BMC Med Genomics. 2024 Jun 3;17(1):152. doi: 10.1186/s12920-024-01915-6.
8
Deficiency of CFB attenuates renal tubulointerstitial damage by inhibiting ceramide synthesis in diabetic kidney disease.补体因子 B 缺乏通过抑制糖尿病肾病中的神经酰胺合成来减轻肾小管间质损伤。
JCI Insight. 2022 Dec 22;7(24):e156748. doi: 10.1172/jci.insight.156748.
9
PTPN14 deficiency alleviates podocyte injury through suppressing inflammation and fibrosis by targeting TRIP6 in diabetic nephropathy.PTPN14 缺乏通过靶向糖尿病肾病中的 TRIP6 抑制炎症和纤维化来减轻足细胞损伤。
Biochem Biophys Res Commun. 2021 Apr 23;550:62-69. doi: 10.1016/j.bbrc.2020.12.030. Epub 2021 Mar 5.
10
JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.JAK/STAT 通路通过足细胞自噬促进糖尿病肾病的进展。
Eur J Pharmacol. 2021 Jul 5;902:174121. doi: 10.1016/j.ejphar.2021.174121. Epub 2021 Apr 24.

引用本文的文献

1
Complement System Inhibitors in Nephrology: An Update-Narrative Review.肾脏病学中的补体系统抑制剂:最新叙述性综述
Int J Mol Sci. 2025 Jun 19;26(12):5902. doi: 10.3390/ijms26125902.
2
Role of local complement activation in kidney fibrosis and repair.局部补体激活在肾纤维化和修复中的作用。
J Clin Invest. 2025 Jun 16;135(12). doi: 10.1172/JCI188345.
3
Complement Factor B Deficiency Is Dispensable for Female Fertility but Affects Microbiome Diversity and Complement Activity.补体因子B缺乏对雌性生育力并非必需,但会影响微生物群多样性和补体活性。

本文引用的文献

1
The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis.抗中性粒细胞胞浆抗体相关性血管炎中的替代补体途径:更多证据和荟萃分析。
Clin Exp Immunol. 2020 Dec;202(3):394-402. doi: 10.1111/cei.13498. Epub 2020 Sep 15.
2
Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.补体因子 B 突变导致替代补体途径的大量液相处方失调可导致非典型溶血尿毒症综合征。
Kidney Int. 2020 Nov;98(5):1265-1274. doi: 10.1016/j.kint.2020.05.028. Epub 2020 Jun 12.
3
Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis.
Int J Mol Sci. 2025 Feb 6;26(3):1393. doi: 10.3390/ijms26031393.
4
Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies.补体经典及替代途径激活促进糖尿病肾病进展:一项基于肾活检的肾小球蛋白质组学研究
Sci Rep. 2025 Jan 2;15(1):495. doi: 10.1038/s41598-024-84900-4.
5
mTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets.mTOR信号通路:糖尿病肾病进展中的关键因素及治疗靶点。
Genes Dis. 2024 Mar 8;12(2):101260. doi: 10.1016/j.gendis.2024.101260. eCollection 2025 Mar.
6
[Inhibition of miR-30d-5p promotes mitochondrial autophagy and alleviates high glucose-induced injury in podocytes].[抑制miR-30d-5p可促进线粒体自噬并减轻高糖诱导的足细胞损伤]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Dec 25;53(6):756-764. doi: 10.3724/zdxbyxb-2024-0504.
7
MicroRNA-29b Plays a Vital Role in Podocyte Injury and Glomerular Diseases through Inducing Mitochondrial Dysfunction.MicroRNA-29b 通过诱导线粒体功能障碍在足细胞损伤和肾小球疾病中发挥重要作用。
Int J Biol Sci. 2024 Sep 3;20(12):4654-4673. doi: 10.7150/ijbs.93506. eCollection 2024.
8
Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction.心脏射血分数保留的心力衰竭患者的肾脏损伤的蛋白质组学相关性及其预后意义。
J Am Heart Assoc. 2024 Sep 3;13(17):e033660. doi: 10.1161/JAHA.123.033660. Epub 2024 Aug 29.
9
Podocyte-targeted therapies - progress and future directions.足细胞靶向治疗 - 进展与未来方向。
Nat Rev Nephrol. 2024 Oct;20(10):643-658. doi: 10.1038/s41581-024-00843-z. Epub 2024 May 9.
10
METTL3 regulates glucose transporter expression in placenta exposed to hyperglycemia through the mTOR signaling pathway.METTL3 通过 mTOR 信号通路调节高血糖暴露下胎盘内葡萄糖转运体的表达。
Chin Med J (Engl). 2024 Jul 5;137(13):1563-1575. doi: 10.1097/CM9.0000000000002840. Epub 2023 Oct 24.
补体替代途径的激活可预测狼疮肾炎患者的肾脏结局。
Lupus. 2020 Jul;29(8):862-871. doi: 10.1177/0961203320925165. Epub 2020 May 14.
4
Rheb1 protects against cisplatin-induced tubular cell death and acute kidney injury via maintaining mitochondrial homeostasis.雷帕霉素靶蛋白 1 通过维持线粒体动态平衡来防止顺铂诱导的肾小管细胞死亡和急性肾损伤。
Cell Death Dis. 2020 May 13;11(5):364. doi: 10.1038/s41419-020-2539-4.
5
Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes.原花青素通过激活足细胞中的 PP2A 减轻糖尿病肾病。
Nat Commun. 2019 Oct 4;10(1):4523. doi: 10.1038/s41467-019-12433-w.
6
Protein phosphatase 2A modulates podocyte maturation and glomerular functional integrity in mice.蛋白磷酸酶 2A 调节小鼠足细胞的成熟和肾小球的功能完整性。
Cell Commun Signal. 2019 Aug 6;17(1):91. doi: 10.1186/s12964-019-0402-y.
7
Post-transplant Alternative Complement Pathway Activation Influences Kidney Allograft Function.移植后替代补体途径的激活影响肾移植功能。
Arch Immunol Ther Exp (Warsz). 2019 Jun;67(3):171-177. doi: 10.1007/s00005-019-00541-w. Epub 2019 Apr 26.
8
mTORC1 Overactivation as a Key Aging Factor in the Progression to Type 2 Diabetes Mellitus.mTORC1过度激活作为2型糖尿病进展中的关键衰老因素。
Front Endocrinol (Lausanne). 2018 Oct 16;9:621. doi: 10.3389/fendo.2018.00621. eCollection 2018.
9
Complement deposition on renal histopathology of patients with diabetic nephropathy.补体在糖尿病肾病患者肾组织病理学中的沉积。
Diabetes Metab. 2019 Sep;45(4):363-368. doi: 10.1016/j.diabet.2018.08.011. Epub 2018 Sep 19.
10
Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases.靶向补体介导疾病中的替代和凝集素途径成分的策略。
Front Immunol. 2018 Aug 8;9:1851. doi: 10.3389/fimmu.2018.01851. eCollection 2018.